AW
BSX icon

Alaethes Wealth’s Boston Scientific BSX Stock Holding History

Alaethes Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,138
Closed -$1.01M – 113
2026
Q1 		$1.01M Buy
16,138
+382
+2% +$30.6K 0.29% 79
2025
Q4 		$1.5M Sell
15,756
-29
-0.2% -$2.84K 0.42% 74
2025
Q3 		$1.54M Buy
15,785
+1,704
+12% +$176K 0.44% 78
2025
Q2 		$1.51M Buy
+14,081
New +$1.42M 0.45% 75
2022
Q1 		– Sell
-38
Closed -$2K – 297
2021
Q4 		$2K Hold
38
– – ﹤0.01% 252
2021
Q3 		$2K Hold
38
– – ﹤0.01% 239
2021
Q2 		$2K Buy
+38
New +$1.6K ﹤0.01% 235

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alaethes Wealth's BSX Position: Q2 2026 in Review

Alaethes Wealth sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 16,138 shares — an estimated $1.01M sold.

Alaethes Wealth first reported a position in BSX in Q2 2021 and held it in 7 quarters. The position peaked at $1.54M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Alaethes Wealth reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Alaethes Wealth sold 16,138 Boston Scientific shares in Q2 2026, an estimated $1.01M.
  • Alaethes Wealth first reported a position in Boston Scientific in Q2 2021 and held it in 7 quarters.
  • Alaethes Wealth's Boston Scientific position peaked at $1.54M in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Alaethes Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.